Clinical Trial Summary
This will be a two-phase protocol. Phase 1 will include the development of the peanut-based
school food, and a small formative research study on the acceptability and consumption of the
school food study intervention. This will occur among children 5-12 yr in the Mion district,
60 school aged children between 6-12 years old will be recruited to participate in a 3 week
consumption and acceptability study. An integral part of the food development process is
acceptability testing. A child must like and want to eat a new food if it is to be consumed
as prescribed and effective in potential improving linear growth and cognitive performance.
This study will confirm that food developed for the school feeding clinical trial will be
consumed as dosed and what additional snack food offerings may be useful in encouraging
consumption.
Phase 2 will be a individually randomized, investigator blinded, controlled clinical
effectiveness trial of a peanut-based school meal with and without milk powder compared to a
control meal for linear growth and cognitive performance. 880 children 5 to 12 years old,
healthy, enrolled in primary school, including kindergarten at 6 selected schools in the Mion
district will be randomized to receive one of three school foods, a peanut-based food with
milk, a peanut-based food without milk and a control group composed of commonly available
tuber/cereal. The sample size accounts for up to 15% attrition for a final sample size of 750
with a total 250 eligible children enrolled in each group. Enrolled children will receive the
meal daily during the school lunch period for an entire school year. At enrollment and upon
completion, anthropometric measurements and body composition data will be collected and a
tablet- based, language independent cognitive test battery will be administered. Basic
demographic information and school attendance information will be collected as well.